biOasis Technologies Ord Shs V.BTI

Primary Symbol: V.BTI.H Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Biodexa's CEO

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Dec 22, 2022 12:19pm

66 Views

Post# 35187327

RE:RE:RE:Biodexa's CEO

So he believes Biodexa's CEO is much more promtional? Do you think Biodexa's CEO is a "massive, shameless pump job. Wow," to use your words?

Of course I never said that. Just more of your distortion and gaslighting.

It appears I'm not even at the first intermission of this endless nightmare Trump Rally.

So did you buy before the "merger" and get caught in the down draft? Can't get out now? Give it up. Take the loss and you can get back to bashing. It suits you better.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price